Apogee Therapeutics, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APGE and other ETFs, options, and stocks.

About APGE

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications.

CEO

Michael Henderson

CEOMichael Henderson

Employees

196

Employees196

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2022

Founded2022

Employees

196

Employees196

APGE Key Statistics

Market cap

2.42B

Market cap2.42B

Price-Earnings ratio

-11.47

Price-Earnings ratio-11.47

Dividend yield

—

Dividend yield—

Average volume

657.92K

Average volume657.92K

High today

$40.71

High today$40.71

Low today

$39.23

Low today$39.23

Open price

$39.95

Open price$39.95

Volume

426.58K

Volume426.58K

52 Week high

$63.50

52 Week high$63.50

52 Week low

$26.20

52 Week low$26.20

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own APGE. This list is generated using Robinhood data, and it’s not a recommendation.

Apogee Therapeutics, Inc.

Why Robinhood?

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. Show more

APGE Key Statistics

Analyst ratings

100%

People also own

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications.